Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma
Condition(s):B Cell Lymphoma; T Cell LymphomaLast Updated:July 20, 2011Terminated
Hide Studies Not Open or Pending
Condition(s):B Cell Lymphoma; T Cell LymphomaLast Updated:July 20, 2011Terminated
Condition(s):Low-Grade B-cell LymphomaLast Updated:September 22, 2022Completed
Condition(s):Cancer of Ovary; Neoplasms, Ovarian; Ovarian Cancer Stage IV; Ovarian Cancer Recurrent; Ovarian Cancer Stage III; Ovary CancerLast Updated:December 22, 2020Terminated
Condition(s):Healthy VolunteersLast Updated:March 28, 2014Completed
Condition(s):Glioma; Malignant Glioma; Astrocytoma, Grade II; Oligodendroglioma; Glioma, Astrocytic; Oligoastrocytoma, MixedLast Updated:March 27, 2023Active, not recruiting
Condition(s):MelanomaLast Updated:October 2, 2015Terminated
Condition(s):Solid CancerLast Updated:February 1, 2021Terminated
Condition(s):Brain and Central Nervous System TumorsLast Updated:July 18, 2018Terminated
Condition(s):Astrocytoma; Oligoastrocytoma; OligodendrogliomaLast Updated:December 8, 2015Completed
Condition(s):Prostate CancerLast Updated:September 10, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.